Biomarker Testing for Patients With Advanced/Metastatic Nonsquamous NSCLC in the United States of America, 2015 to 2021

INTRODUCTION: NSCLC is a solid tumor with a growing number of actionable biomarkers that may inform treatment. Current guidelines recommend a broad, panel-based approach be taken to identify actionable markers. This retrospective study used a deidentified electronic health records database in the Un...

Descripción completa

Detalles Bibliográficos
Autores principales: Hess, Lisa M., Krein, Peter M., Haldane, Diane, Han, Yimei, Sireci, Anthony N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168140/
https://www.ncbi.nlm.nih.gov/pubmed/35677681
http://dx.doi.org/10.1016/j.jtocrr.2022.100336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168140/
https://www.ncbi.nlm.nih.gov/pubmed/35677681
http://dx.doi.org/10.1016/j.jtocrr.2022.100336

Ejemplares similares